Single-cell study of acute myeloid leukemia
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This study is for adults with acute myeloid leukemia (AML) whose cancer has returned or is not responding to treatment. Researchers will analyze your leukemia cells to learn more about the disease and possibly find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have acute myeloid leukemia (AML) that has come back after treatment or did not get better with treatment.
- You have leukemia cells (blasts) in your blood (your doctor can check this).
- You can understand and communicate in French, or you have a translator to help.
- You are on a social security plan (health insurance) that covers you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This non-interventional study follows adults with acute myeloid leukemia (AML) to better understand the disease and how patients do in real-world care. It may help researchers compare outcomes across different types of AML, but you would not receive a study treatment just for joining.
This trial looks at how childhood, teen, and young adult acute myeloid leukemia (AML) changes at the genetic level and how cells respond to multiple drugs. It may help doctors understand which treatments work best and how leukemia interacts with supportive cells in the bone marrow.
This study collects health information from young people with a type of blood cancer called acute myeloid leukemia (AML). The goal is to learn more about the disease and improve future treatments. If you are under 25 and being treated for AML at a hospital in France, you might be able to join.
This study tests a personalized approach to treating acute myeloid leukemia (AML) that has come back or stopped responding to prior treatments. Researchers will analyze your leukemia cells in the lab to find the best drug combination for your specific cancer, with the goal of improving treatment outcomes.
This study looks at how acute myeloid leukemia behaves over time in adults and may help doctors better predict outcomes. You might be eligible if you have AML and agree to take part in research.
This study uses advanced tests (genetics and other 'omics' methods) to better understand your leukemia and find a treatment that targets its specific features. It may help if standard treatments haven't worked or stopped working.
Hear when a new Acute Myeloid Leucemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.